Literature DB >> 28509106

Posterior reversible encephalopathy syndrome in a uremic patient with autosomal recessive polycystic kidney disease.

Tadashi Yoshida1,2, Ken Hiratsuka3, Maho Yamashita4, Ayumi Matsui3, Matsuhiko Hayashi4,5.   

Abstract

Posterior reversible encephalopathy syndrome (PRES) is characterized by headache, seizures, altered mental status, and visual disturbance. It is diagnosed by the presence of both clinical symptoms and radiographic findings on the parietal-occipital lobes. We here report a 61-year-old woman with non-compensative liver cirrhosis and chronic kidney disease, presenting with uremia-induced PRES. She expressed loss of consciousness and subsequent visual disturbance, during the progression of uremia. She was treated with hemodiafiltration therapy, and the symptoms of PRES fully improved. The case is of particular interest, in that the appearance of abnormal findings on magnetic resonance imaging was delayed more than 2 weeks, as compared to that of clinical symptoms. The etiology of chronic kidney disease in the patient was considered to be autosomal recessive polycystic kidney disease, and we performed DNA sequencing analysis on the polycystic kidney and hepatic disease 1 gene. Two homozygous missense mutations were found in the patient and may combinatorially affect the disease. This case raises a possibility that the incidence of PRES is much higher if the radiological examination is performed more frequently.

Entities:  

Keywords:  Autosomal recessive polycystic kidney disease; Magnetic resonance imaging; Posterior reversible encephalopathy syndrome

Year:  2015        PMID: 28509106      PMCID: PMC5413773          DOI: 10.1007/s13730-015-0176-z

Source DB:  PubMed          Journal:  CEN Case Rep        ISSN: 2192-4449


  13 in total

Review 1.  Posterior reversible encephalopathy syndrome in intensive care medicine.

Authors:  Giuseppe Servillo; Francesca Bifulco; Edoardo De Robertis; Ornella Piazza; Pasquale Striano; Fabio Tortora; Salvatore Striano; Rosalba Tufano
Journal:  Intensive Care Med       Date:  2006-11-21       Impact factor: 17.440

2.  Posterior leukoencephalopathy without severe hypertension: utility of diffusion-weighted MRI.

Authors:  H Ay; F S Buonanno; P W Schaefer; D A Le; B Wang; R G Gonzalez; W J Koroshetz
Journal:  Neurology       Date:  1998-11       Impact factor: 9.910

Review 3.  Autosomal recessive polycystic kidney disease.

Authors:  K Zerres; S Rudnik-Schöneborn; C Steinkamm; G Mücher
Journal:  Nephrol Dial Transplant       Date:  1996       Impact factor: 5.992

4.  Diffusion-weighted imaging shows cytotoxic and vasogenic edema in eclampsia.

Authors:  S Koch; A Rabinstein; S Falcone; A Forteza
Journal:  AJNR Am J Neuroradiol       Date:  2001 Jun-Jul       Impact factor: 3.825

5.  Comprehensive genomic analysis of PKHD1 mutations in ARPKD cohorts.

Authors:  A M Sharp; L M Messiaen; G Page; C Antignac; M-C Gubler; L F Onuchic; S Somlo; G G Germino; L M Guay-Woodford
Journal:  J Med Genet       Date:  2005-04       Impact factor: 6.318

6.  A complete mutation screen of PKHD1 in autosomal-recessive polycystic kidney disease (ARPKD) pedigrees.

Authors:  Sandro Rossetti; Roser Torra; Eliecer Coto; Mark Consugar; Vickie Kubly; Serafin Málaga; Mercedes Navarro; Mounif El-Youssef; Vicente E Torres; Peter C Harris
Journal:  Kidney Int       Date:  2003-08       Impact factor: 10.612

Review 7.  PKHD1 mutations in autosomal recessive polycystic kidney disease (ARPKD).

Authors:  Carsten Bergmann; Jan Senderek; Fabian Küpper; Frank Schneider; Christian Dornia; Ellen Windelen; Thomas Eggermann; Sabine Rudnik-Schöneborn; Jutta Kirfel; Laszlo Furu; Luiz F Onuchic; Sandro Rossetti; Peter C Harris; Stefan Somlo; Lisa Guay-Woodford; Gregory G Germino; Markus Moser; Reinhard Büttner; Klaus Zerres
Journal:  Hum Mutat       Date:  2004-05       Impact factor: 4.878

8.  Milder presentation of recessive polycystic kidney disease requires presence of amino acid substitution mutations.

Authors:  Laszlo Furu; Luiz F Onuchic; Ali Gharavi; Xiaoying Hou; Ernie L Esquivel; Yasuyuki Nagasawa; Carsten Bergmann; Jan Senderek; Ellis Avner; Klaus Zerres; Gregory G Germino; Lisa M Guay-Woodford; Stefan Somlo
Journal:  J Am Soc Nephrol       Date:  2003-08       Impact factor: 10.121

9.  Balance between IL-1 beta, TNF-alpha, and their specific inhibitors in chronic renal failure and maintenance dialysis. Relationships with activation markers of T cells, B cells, and monocytes.

Authors:  B Descamps-Latscha; A Herbelin; A T Nguyen; P Roux-Lombard; J Zingraff; A Moynot; C Verger; D Dahmane; D de Groote; P Jungers
Journal:  J Immunol       Date:  1995-01-15       Impact factor: 5.422

10.  Clinical and molecular characterization defines a broadened spectrum of autosomal recessive polycystic kidney disease (ARPKD).

Authors:  Magdalena Adeva; Mounif El-Youssef; Sandro Rossetti; Patrick S Kamath; Vickie Kubly; Mark B Consugar; Dawn M Milliner; Bernard F King; Vicente E Torres; Peter C Harris
Journal:  Medicine (Baltimore)       Date:  2006-01       Impact factor: 1.889

View more
  3 in total

Review 1.  Autosomal Recessive Polycystic Kidney Disease-The Clinical Aspects and Diagnostic Challenges.

Authors:  Dorota Wicher; Łukasz Obrycki; Irena Jankowska
Journal:  J Pediatr Genet       Date:  2020-07-29

2.  Clinical courses and complications of young adults with Autosomal Recessive Polycystic Kidney Disease (ARPKD).

Authors:  Kathrin Burgmaier; Samuel Kilian; Bert Bammens; Thomas Benzing; Heiko Billing; Anja Büscher; Matthias Galiano; Franziska Grundmann; Günter Klaus; Djalila Mekahli; Laurence Michel-Calemard; Gordana Milosevski-Lomic; Bruno Ranchin; Katja Sauerstein; Susanne Schaefer; Rukshana Shroff; Rosalie Sterenborg; Sarah Verbeeck; Lutz T Weber; Dorota Wicher; Elke Wühl; Jörg Dötsch; Franz Schaefer; Max C Liebau
Journal:  Sci Rep       Date:  2019-05-28       Impact factor: 4.379

3.  Association of kidney function with posterior reversible encephalopathy syndrome in children.

Authors:  Shruti M Shah; Andrew M South
Journal:  Clin Nephrol       Date:  2022-07       Impact factor: 1.243

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.